196 related articles for article (PubMed ID: 30926899)
1. Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells.
Niogret C; Miah SMS; Rota G; Fonta NP; Wang H; Held W; Birchmeier W; Sexl V; Yang W; Vivier E; Ho PC; Brossay L; Guarda G
Nat Commun; 2019 Mar; 10(1):1444. PubMed ID: 30926899
[TBL] [Abstract][Full Text] [Related]
2. Protein Tyrosine Phosphatase SHP-2 Is Involved in the Interleukin-21-Induced Activation of Extracellular Signal-Regulated Kinase 1/2.
Jin L; Nara H; Rahman M; Takeda Y; Araki A; Asao H
Tohoku J Exp Med; 2018 Mar; 244(3):187-193. PubMed ID: 29503347
[TBL] [Abstract][Full Text] [Related]
3. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
Lowin-Kropf B; Kunz B; Beermann F; Held W
J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
[TBL] [Abstract][Full Text] [Related]
4. SHP-1 phosphatase is a critical regulator in preventing natural killer cell self-killing.
Mahmood S; Kanwar N; Tran J; Zhang ML; Kung SK
PLoS One; 2012; 7(8):e44244. PubMed ID: 22952938
[TBL] [Abstract][Full Text] [Related]
5. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
[TBL] [Abstract][Full Text] [Related]
6. PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness.
Yang M; Li D; Chang Z; Yang Z; Tian Z; Dong Z
J Exp Med; 2015 Feb; 212(2):253-65. PubMed ID: 25624444
[TBL] [Abstract][Full Text] [Related]
7. Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
Bou-Tayeh B; Laletin V; Salem N; Just-Landi S; Fares J; Leblanc R; Balzano M; Kerdiles YM; Bidaut G; Hérault O; Olive D; Aurrand-Lions M; Walzer T; Nunès JA; Fauriat C
Front Immunol; 2021; 12():730970. PubMed ID: 34975835
[TBL] [Abstract][Full Text] [Related]
8. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase.
Mason LH; Gosselin P; Anderson SK; Fogler WE; Ortaldo JR; McVicar DW
J Immunol; 1997 Nov; 159(9):4187-96. PubMed ID: 9379012
[TBL] [Abstract][Full Text] [Related]
9. Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity.
Wagner JA; Wong P; Schappe T; Berrien-Elliott MM; Cubitt C; Jaeger N; Lee M; Keppel CR; Marin ND; Foltz JA; Marsala L; Neal CC; Sullivan RP; Schneider SE; Keppel MP; Saucier N; Cooper MA; Fehniger TA
Cell Rep; 2020 Jun; 31(9):107720. PubMed ID: 32492428
[TBL] [Abstract][Full Text] [Related]
10. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
[TBL] [Abstract][Full Text] [Related]
11. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
12. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase.
Nakamura MC; Niemi EC; Fisher MJ; Shultz LD; Seaman WE; Ryan JC
J Exp Med; 1997 Feb; 185(4):673-84. PubMed ID: 9034146
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine phosphatase Shp-2 confers resistance to colonic inflammation by driving goblet cell function and crypt regeneration.
Gagné-Sansfacon J; Langlois A; Langlois MJ; Coulombe G; Tremblay S; Vaillancourt-Lavigueur V; Qu CK; Menendez A; Rivard N
J Pathol; 2019 Jan; 247(1):135-146. PubMed ID: 30376595
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons.
Fiorentini C; Mattanza C; Collo G; Savoia P; Spano P; Missale C
J Neurochem; 2011 Apr; 117(2):253-63. PubMed ID: 21272002
[TBL] [Abstract][Full Text] [Related]
15. High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors.
Marçais A; Marotel M; Degouve S; Koenig A; Fauteux-Daniel S; Drouillard A; Schlums H; Viel S; Besson L; Allatif O; Bléry M; Vivier E; Bryceson Y; Thaunat O; Walzer T
Elife; 2017 Sep; 6():. PubMed ID: 28875936
[TBL] [Abstract][Full Text] [Related]
16. Importance of protein-tyrosine phosphatase-alpha catalytic domains for interactions with SHP-2 and interleukin-1-induced matrix metalloproteinase-3 expression.
Wang Q; Rajshankar D; Laschinger C; Talior-Volodarsky I; Wang Y; Downey GP; McCulloch CA
J Biol Chem; 2010 Jul; 285(29):22308-17. PubMed ID: 20472558
[TBL] [Abstract][Full Text] [Related]
17. Differential roles for IL-15R alpha-chain in NK cell development and Ly-49 induction.
Kawamura T; Koka R; Ma A; Kumar V
J Immunol; 2003 Nov; 171(10):5085-90. PubMed ID: 14607906
[TBL] [Abstract][Full Text] [Related]
18. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
Yusa S; Campbell KS
J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
[TBL] [Abstract][Full Text] [Related]
19. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
Yu TK; Caudell EG; Smid C; Grimm EA
J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.
Le Dréan E; Vély F; Olcese L; Cambiaggi A; Guia S; Krystal G; Gervois N; Moretta A; Jotereau F; Vivier E
Eur J Immunol; 1998 Jan; 28(1):264-76. PubMed ID: 9485206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
